Bob Blomquist


Summit Biolabs, Inc.


Requested Donation

Bob's Summary

Bob Blomquist has over 35 years of healthcare industry experience covering development and commercialization of biopharmaceuticals, diagnostics and medical devices. He has worked both as a consultant and as a senior executive at large corporations and new venture startups. He is the CEO of Summit Biolabs, Inc., and he is also the CEO of Sinfonia Biotherapeutics, Inc. Previous experience includes Head of worldwide strategy at EG&G Wallac Oy, President & Founder at Wallac Canada, and General Manager at Pharmacia Diagnostics Canada. He has a track record of success launching innovative healthcare products and creating new markets. As business development lead, he has a track record of success in acquiring drug and device assets, and intellectual property. He has been an independent board member. At Blomquist & Associates, he is an independent advisor to private equity investors, having advised on over 95 investments in values up to $2B, and has been an advisor to 24 life science companies. He has a breadth of disease and therapeutic area experience, including oncology, Infectious, neurodegenerative, genetic and orphan diseases.

About Bob

  • Span of Control

    The number of people reporting to them

  • Industry

    Biotechnology Research

  • Size of Company

    In terms of revenue

  • Employees of Company

    The number of people working for this company

  • Business Function

    Administration (CEO, Pres., GM, etc)

Interested in meeting with Bob?

Click here to learn more!

My "Bold Ask" to Vendors

...compelling reasons I would take a meeting.

Meetings I'm Not Interested In

Supported Causes & Charities